UpdatesGeneral Updates
Indegene reported FY26 revenue of INR 3,510.5 Cr (up 23.6%) and PAT of INR 401.1 Cr.
Indegene LimitedINDGN · Filed with the exchange
The company increased its dividend to INR 2.25/share.
Strategic focus on AI-led operating models and integration of BioPharm (INR 882 Cr acquisition) is key for future growth and margin expansion.
No comments yet. Be the first.